Select Publications
Journal articles
2024, 'Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.', Circulation, http://dx.doi.org/10.1161/CIRCULATIONAHA.124.069568
,2024, 'The contribution of sodium reduction and potassium increase to the blood pressure lowering observed in the Salt Substitute and Stroke Study', Journal of Human Hypertension, 38, pp. 298 - 306, http://dx.doi.org/10.1038/s41371-024-00896-4
,2024, 'Potassium-Enriched Salt Substitutes: A Review of Recommendations in Clinical Management Guidelines', Hypertension, 81, pp. 400 - 414, http://dx.doi.org/10.1161/HYPERTENSIONAHA.123.21343
,2024, 'Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria', Circulation, 149, pp. 450 - 462, http://dx.doi.org/10.1161/CIRCULATIONAHA.123.067584
,2024, 'Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial', Kidney International Reports, 9, pp. 347 - 355, http://dx.doi.org/10.1016/j.ekir.2023.11.024
,2024, 'Switching the World's Salt Supply—Learning from Iodization to Achieve Potassium Enrichment', Advances in Nutrition, 15, pp. 100148, http://dx.doi.org/10.1016/j.advnut.2023.100148
,2024, 'The effect of salt substitution on frequency and severity of headache: results from the SSaSS cluster-randomised controlled trial of 20,995 participants', European Journal of Clinical Nutrition, pp. 1 - 6, http://dx.doi.org/10.1038/s41430-024-01419-7
,2024, 'Secondary Analysis of the Salt Substitute and Stroke Study (SSaSS): Effects of Potassium-Enriched Salt on Cardiac Outcomes.', Hypertension, 81, pp. 1031 - 1040, http://dx.doi.org/10.1161/HYPERTENSIONAHA.123.22410
,2023, 'Changes in sodium levels in Australian packaged foods between 2014 and 2019: an interrupted time series analysis of the impact of the Victorian Salt Reduction Partnership’s media advocacy strategy', International Journal of Behavioral Nutrition and Physical Activity, 20, pp. 71, http://dx.doi.org/10.1186/s12966-023-01475-5
,2023, 'Factors influencing the time to ethics and governance approvals for clinical trials: a retrospective cross-sectional survey', Trials, 24, pp. 779, http://dx.doi.org/10.1186/s13063-023-07802-2
,2023, 'Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality', European Heart Journal, 44, pp. 4448 - 4457, http://dx.doi.org/10.1093/eurheartj/ehad535
,2023, 'A novel approach to estimate product-specific greenhouse gas emissions for 23,550 Australian packaged foods and beverages', Journal of Cleaner Production, 425, pp. 138816, http://dx.doi.org/10.1016/j.jclepro.2023.138816
,2023, 'Sodium glucose co-transporter 2 inhibition increases epidermal growth factor expression and improves outcomes in patients with type 2 diabetes', Kidney International, 104, pp. 828 - 839, http://dx.doi.org/10.1016/j.kint.2023.07.007
,2023, 'Protocol for a randomized controlled trial of medically tailored meals compared to usual care among individuals with type 2 diabetes in Australia', Contemporary Clinical Trials, 132, http://dx.doi.org/10.1016/j.cct.2023.107307
,2023, 'Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE Trial', Circulation, 148, pp. 651 - 660, http://dx.doi.org/10.1161/CIRCULATIONAHA.123.065251
,2023, 'Evaluation of a state-wide intervention on salt intake in primary schoolchildren living in Victoria, Australia', Public Health Nutrition, 26, pp. 1456 - 1467, http://dx.doi.org/10.1017/S1368980023000332
,2023, 'Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials', Journal of the American Heart Association, 12, pp. e028516, http://dx.doi.org/10.1161/JAHA.122.028516
,2023, 'A meta-analysis of GFR slope as a surrogate endpoint for kidney failure', Nature Medicine, 29, pp. 1867 - 1876, http://dx.doi.org/10.1038/s41591-023-02418-0
,2023, 'Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial', American Journal of Kidney Diseases, 82, pp. 84 - 96.e1, http://dx.doi.org/10.1053/j.ajkd.2022.12.015
,2023, 'P29-040-23 The Effect of Mycoprotein Intake on Biomarkers of Human Health: A Systematic Review and Meta-Analysis', Current Developments in Nutrition, 7, pp. 101428 - 101428, http://dx.doi.org/10.1016/j.cdnut.2023.101428
,2023, 'The effect of mycoprotein intake on biomarkers of human health: a systematic review and meta-analysis', American Journal of Clinical Nutrition, 118, pp. 141 - 150, http://dx.doi.org/10.1016/j.ajcnut.2023.03.019
,2023, 'Good for your heart and safe for your toes: A patient-level meta-analysis of DAPA-HF and DELIVER', European Heart Journal, 44, pp. 2184 - 2186, http://dx.doi.org/10.1093/eurheartj/ehad315
,2023, 'Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering', BMJ Open Diabetes Research and Care, 11, pp. e003270, http://dx.doi.org/10.1136/bmjdrc-2022-003270
,2023, 'The importance of targeting multiple risk markers in patients with type 2 diabetes: A post-hoc study from the CANVAS programme', Diabetes, Obesity and Metabolism, 25, pp. 1638 - 1645, http://dx.doi.org/10.1111/dom.15018
,2023, 'Sodium content in Swedish processed food items compared to other countries', European Journal of Preventive Cardiology, 30, http://dx.doi.org/10.1093/eurjpc/zwad125.028
,2023, 'The Proportion of Dietary Salt Replaced with Potassium-Enriched Salt in the SSaSS: Implications for Scale-Up', Hypertension, 80, pp. 956 - 965, http://dx.doi.org/10.1161/HYPERTENSIONAHA.122.20115
,2023, 'Heterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial', JAMA, 329, pp. 1160 - 1169, http://dx.doi.org/10.1001/jama.2023.3322
,2023, 'Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial', Nature Medicine, 29, pp. 973 - 981, http://dx.doi.org/10.1038/s41591-023-02286-8
,2023, 'Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation', Circulation, 147, pp. 925 - 929, http://dx.doi.org/10.1161/CIRCULATIONAHA.122.063378
,2023, 'TREATMENT EFFECT OF CANAGLIFLOZIN FOR PATIENTS ON THERAPY FOR HEART FAILURE: POOLED ANALYSIS OF THE CANVAS PROGRAM AND CREDENCE TRIAL', Journal of the American College of Cardiology, 81, pp. 283, http://dx.doi.org/10.1016/s0735-1097(23)00727-1
,2023, 'Estimated Dietary and Health Impact of the World Health Organization's Global Sodium Benchmarks on Packaged Foods in Australia: A Modeling Study', Hypertension, 80, pp. 541 - 549, http://dx.doi.org/10.1161/HYPERTENSIONAHA.122.20105
,2023, 'Hypertension treatment capacity in India by increased workforce, greater task-sharing, and extended prescription period: a modelling study', The Lancet Regional Health - Southeast Asia, 10, pp. 100124, http://dx.doi.org/10.1016/j.lansea.2022.100124
,2023, 'Evaluation of a Salt-Reduction Consumer Awareness Campaign Targeted at Parents Residing in the State of Victoria, Australia', Nutrients, 15, pp. 991, http://dx.doi.org/10.3390/nu15040991
,2023, 'Cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressure', Heart, 109, pp. 1698 - 1705, http://dx.doi.org/10.1136/heartjnl-2022-322300
,2023, 'Effectiveness of a Sodium-Reduction Smartphone App and Reduced-Sodium Salt to Lower Sodium Intake in Adults With Hypertension: Findings From the Salt Alternatives Randomized Controlled Trial', JMIR mHealth and uHealth, 11, pp. e43675, http://dx.doi.org/10.2196/43675
,2023, 'Outcomes of a state-wide salt reduction initiative in adults living in Victoria, Australia', European Journal of Nutrition, 62, pp. 3055 - 3067, http://dx.doi.org/10.1007/s00394-023-03210-z
,2023, 'Sodium Content and Labelling of Packaged Foods and Beverages in Nigeria: A Cross-Sectional Study', Nutrients, 15, pp. 27, http://dx.doi.org/10.3390/nu15010027
,2023, 'Sodium content in processed food items in Sweden compared to other countries: a cross-sectional multinational study', Frontiers in Public Health, 11, pp. 1182132, http://dx.doi.org/10.3389/fpubh.2023.1182132
,2023, 'Stakeholder perspectives on Nigeria's national sodium reduction program: Lessons for implementation and scale-up', PLoS ONE, 18, pp. e0280226, http://dx.doi.org/10.1371/journal.pone.0280226
,2023, 'Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial', International Journal of Cardiology, 395, http://dx.doi.org/10.1016/j.ijcard.2023.131444
,2023, 'Criterion validation of nutrient profiling systems: a systematic review and meta-analysis', American Journal of Clinical Nutrition, 119, http://dx.doi.org/10.1016/j.ajcnut.2023.10.013
,2023, 'S-16-1: RESISTANT HYPERTENISION: CLINICAL CHARACTERISTICS AND BLOOD PRESSURE CONTROL', Journal of Hypertension, 41, pp. e42, http://dx.doi.org/10.1097/01.hjh.0000913112.64878.4e
,2022, 'Endotrophin is a risk marker of complications in CANagliflozin cardioVascular Assessment Study (CANVAS): a randomized controlled trial', Cardiovascular Diabetology, 21, pp. 261, http://dx.doi.org/10.1186/s12933-022-01666-7
,2022, 'Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure', Cardiovascular Diabetology, 21, pp. 194, http://dx.doi.org/10.1186/s12933-022-01619-0
,2022, 'Socio-economic difference in purchases of ultra-processed foods in Australia: an analysis of a nationally representative household grocery purchasing panel', International Journal of Behavioral Nutrition and Physical Activity, 19, pp. 148, http://dx.doi.org/10.1186/s12966-022-01389-8
,2022, 'The effects of government policies targeting ethics and governance processes on clinical trial activity and expenditure: a systematic review', Humanities and Social Sciences Communications, 9, pp. 266, http://dx.doi.org/10.1057/s41599-022-01269-3
,2022, 'Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials', The Lancet, 400, pp. 1788 - 1801, http://dx.doi.org/10.1016/S0140-6736(22)02074-8
,2022, 'Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria', Journal of the American College of Cardiology, 80, pp. 1721 - 1731, http://dx.doi.org/10.1016/j.jacc.2022.08.772
,2022, 'Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS', Diabetes Care, 45, pp. 2644 - 2652, http://dx.doi.org/10.2337/dc22-0866
,2022, 'Testing the Feasibility and Dietary Impact of a “Produce Prescription” Program for Adults with Undermanaged Type 2 Diabetes and Food Insecurity in Australia', Journal of Nutrition, 152, pp. 2409 - 2418, http://dx.doi.org/10.1093/jn/nxac152
,